In the two years since the COVID-19 pandemic started, Americans have lived through the most significant economic disruption since the Great Depression and the deadliest public health event since the Spanish Flu more than a century ago. But the country has also seen an incredible response from health departments and pharmaceutical companies to blunt the spread of the disease while developing vaccines and innovative therapy to protect or treat the infected.
However, the response to this disease has raised many new issues for hospitals, public health departments and medical professionals — how can organizations safely collect and distribute sensitive personal data that is compliant with HIPAA regulations?